BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10083159)

  • 1. Marginal donors in liver transplantation: the role of donor age.
    De Carlis L; Colella G; Sansalone CV; Aseni P; Rondinara GF; Slim AO; Di Benedetto F; Giacomoni A; Fesce R; Forti D
    Transplant Proc; 1999; 31(1-2):397-400. PubMed ID: 10083159
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the use of marginal liver grafts justified?
    Mueller AR; Platz KP; Krause P; Steinmüller T; Glanemann M; Neumann U; Lobeck H; Neuhaus P
    Transplant Proc; 1999; 31(1-2):401-2. PubMed ID: 10083160
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver transplantation from cadaveric and living donors.
    Lo CM; Lo RJ; Lai CL; Fan ST; Wong J
    Transplant Proc; 1996 Jun; 28(3):1659-60. PubMed ID: 8658826
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor infection and primary nonfunction in liver transplantation.
    Nery JR; Weppler D; Ketchum P; Olson L; Fragulidis GP; Khan MF; Webb MG; Miller J; Tzakis AG
    Transplant Proc; 1997; 29(1-2):481-3. PubMed ID: 9123093
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for severe ischemic injury after liver transplantation.
    Bilbao I; Charco R; Hidalgo E; Lázaro JL; Balsells J; Murio E; Margarit C
    Transplant Proc; 1997; 29(1-2):368-70. PubMed ID: 9123041
    [No Abstract]   [Full Text] [Related]  

  • 6. Living donor transplantation: single center experience.
    Haberal M; Karakayali H; Bilgin N; Arslan G; Büyükpamukçu N; Telatar H; Karamehmetoğlu M; Moray G
    Transplant Proc; 1996 Feb; 28(1):65-7. PubMed ID: 8644342
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of potential liver donors: expanding donor criteria?
    Rull R; García-Valdecasas JC; Momblan D; Grande L; Vidal O; Fuster J; González FX; López-Boado MA; Cabrer K; Visa J
    Transplant Proc; 2002 Feb; 34(1):229-30. PubMed ID: 11959258
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of high-risk liver donors for urgent and elective liver transplantation.
    Briceño J; Pera-Rojas C; Solorzano G; De la Mata M; Pera-Madrazo C
    Transplant Proc; 1999; 31(1-2):440-2. PubMed ID: 10083179
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of donor criteria on postoperative graft function after orthotopic liver transplantation.
    Gruenberger T; Steininger R; Sautner T; Mittlböck M; Mühlbacher F
    Transpl Int; 1994; 7 Suppl 1():S672-4. PubMed ID: 11271336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P
    Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative factors influencing patient outcome after liver transplantation.
    Mueller AR; Platz KP; Krause P; Kahl A; Rayes N; Glanemann M; Lang M; Wex C; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13 Suppl 1():S158-61. PubMed ID: 11111987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of liver transplantation in the North Italy Transplant program.
    Pappalettera M; Scalamogna M; Pizzi C; Sioli V; Cagni N; Sirchia G
    Transplant Proc; 1994 Dec; 26(6):3612-3. PubMed ID: 7998292
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal transplantation in Iran: a single-center study.
    Kayedi M; Golbabaie M; Najafi I; Ganji MR; Naderi GH; Mehraban D; Hakemi M
    Transplant Proc; 2001 Aug; 33(5):2646-7. PubMed ID: 11498104
    [No Abstract]   [Full Text] [Related]  

  • 14. Is donor age a risk factor for poor graft function after orthotopic liver transplantation?
    Tisone G; Romagnoli J; Vennarecci G; Anselmo A; Angelico M; Gandin C; Dauri M; Casciani CU
    Transplant Proc; 1997 Nov; 29(7):2825-6. PubMed ID: 9365577
    [No Abstract]   [Full Text] [Related]  

  • 15. Orthotopic liver transplantation in patients over 60 years of age.
    Jiménez C; Gándara N; Chamorro AG; Romano DR; Rodríguez F; Loinaz C; Palomo JC; Hernández D; García I; Moreno E
    Transplant Proc; 1999 Sep; 31(6):2449-52. PubMed ID: 10500666
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors involved in the functional recovery of a liver graft with particular emphasis on liver steatosis: a multivariate analysis.
    De Carlis L; Giacomoni A; Slim AO; Pirotta V; Di Benedetto F; Manoochehri F; Lauterio A; Sammartino C; Rondinara GF; Forti D
    Transplant Proc; 2001 Aug; 33(5):2720-2. PubMed ID: 11498138
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status of organ transplantation in Japan.
    Amemiya H
    Transplant Proc; 1996 Jun; 28(3):1193-5. PubMed ID: 8658623
    [No Abstract]   [Full Text] [Related]  

  • 18. Review of living related versus cadaveric donors in pediatric liver transplantation: the lyon experience.
    Eid B; Villard F; Stamm D; Mamoux V; Bouvier R; Canterino I; Boillot O; Lachaux A
    Transplant Proc; 2000 Mar; 32(2):453. PubMed ID: 10715477
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil as primary and rescue therapy in intestinal transplantation.
    Tzakis AG; Weppler D; Khan MF; Koutouby R; Romero R; Viciana AL; Raskin J; Nery JR; Thompson J
    Transplant Proc; 1998 Sep; 30(6):2677-9. PubMed ID: 9745545
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver donors: is age a risk factor?
    Busquests J; Figueras J; Torras J; Fabregat J; Rafecas A; Ramos E; Lama C; Jaurrieta E
    Transplant Proc; 1999 Sep; 31(6):2480-1. PubMed ID: 10500679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.